BioScience Health Innovations (BHIC) Revenue (2023 - 2026)

BioScience Health Innovations (BHIC) has reported Revenue for 4 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Revenue fell 41.03% year-over-year to $1.0 million in Q2 2026; TTM through Jun 2026 was $4.5 million, a 7.77% increase from a year earlier, with the FY2025 full-year figure at $5.7 million, up 208.34% from the prior year.
• Revenue was $1.0 million for Q2 2026 at BioScience Health Innovations, up from $750946.0 in the prior quarter.
• Over five years, Revenue peaked at $1.8 million in Q2 2025 and troughed at $32337.0 in Q1 2023.
• A 4-year average of $708470.6 and a median of $591597.5 in 2024 frame the typical range for Revenue.
• Across the five-year window, Revenue surged 758.46% in 2024 and tumbled 41.03% in 2026, its largest moves.
• Over 4 years, Revenue stood at $303628.0 in 2023, then surged by 100.98% to $610222.0 in 2024, then jumped by 157.74% to $1.6 million in 2025, then tumbled by 34.11% to $1.0 million in 2026.
• The last three Revenue figures came in at $1.0 million (Q2 2026), $750946.0 (Q1 2026), and $1.6 million (Q4 2025), per Business Quant data.